 |
/25-car-15702/car-6.jpg?upscale=true&width=600&height=400&name=car-6.jpg) |
Now Possible: Direct CAR Cell Assessment in Solid Tumors
When challenging solid tumors with CAR-engineered cells, a paramount question is whether these cells are capable of entering the tumor microenvironment. But traditional methods have significant drawbacks. For the first time, you can confirm CAR protein expression in FFPE tissue specifically and directly, only from CST. |
|
CAR Expression in Tissue
Analyze the impact of CAR cell engineering on solid tumor penetration by examining IHC data of FFPE cancer tissue. See the CAR linker antibodies for IHC. |
/25-car-15702/module-1-email-6.jpeg?upscale=true&width=180&height=200&name=module-1-email-6.jpeg) |
Interrogate the Tumor Microenvironment
Investigate the tumor microenvironment with an IHC-validated portfolio of highly specific, unconjugated and conjugated antibodies. Innovative SignalStar® multiplex IHC is ideal for visualizing up to eight biomarkers in the same panel. Explore IHC antibodies for TME investigation. |
/25-car-15702/module-2-email-6.jpeg?upscale=true&width=180&height=200&name=module-2-email-6.jpeg) |
Simplify Translational CAR Research |
/25-car-15702/product-1-email-6.jpeg?upscale=true&width=180&height=200&name=product-1-email-6.jpeg)
/25-car-15702/product-2-email-6-updated.png?upscale=true&width=180&height=200&name=product-2-email-6-updated.png)
/25-car-15702/product-3-email-6.jpeg?upscale=true&width=180&height=200&name=product-3-email-6.jpeg)